A detailed history of Bio Impact Capital LLC transactions in Aquestive Therapeutics, Inc. stock. As of the latest transaction made, Bio Impact Capital LLC holds 1,796,750 shares of AQST stock, worth $6.34 Million. This represents 1.4% of its overall portfolio holdings.

Number of Shares
1,796,750
Holding current value
$6.34 Million
% of portfolio
1.4%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$2.4 - $5.09 $4.31 Million - $9.15 Million
1,796,750 New
1,796,750 $8.95 Million

Others Institutions Holding AQST

About Aquestive Therapeutics, Inc.


  • Ticker AQST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,350,700
  • Market Cap $188M
  • Description
  • Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...
More about AQST
Track This Portfolio

Track Bio Impact Capital LLC Portfolio

Follow Bio Impact Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bio Impact Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bio Impact Capital LLC with notifications on news.